ProCE Banner Activity

CE / CME

Respiratory Syncytial Virus in Older Adults: Understanding Risk, Diagnosis, and Evolving Prevention Strategies

Hear expert insights on risk factors for respiratory syncytial virus among adults, the need for a vaccination strategy in this population, and the evolving clinical studies on vaccines for older adults.

Pharmacists: 0.75 contact hour (0.075 CEUs)

Physicians: Maximum of 0.75 AMA PRA Category 1 Credit

Nurses: 0.75 Nursing contact hour

Released: July 21, 2021

Expiration: July 20, 2022

No longer available for credit.

Share

Faculty

Spencer H. Durham

Spencer H. Durham, PharmD, BCPS, BCIDP

Assistant Clinical Professor
Pharmacy Practice
Auburn University Harrison School of Pharmacy
Auburn, Alabama
Clinical Pharmacist Specialist, Infectious Diseases
Department of Pharmacy
Central Alabama Veterans Health Care System
Montgomery, Alabama

Stefan Gravenstein

Stefan Gravenstein, MD, MPH

Greer Professor of Geriatrics
Alpert Medical School of Brown University
Providence, Rhode Island

Barbara Resnick

Barbara Resnick, PhD, CRNP

Professor
School of Nursing
University of Maryland
Nurse Practitioner
Roland Park Pace
Baltimore, Maryland

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Janssen Therapeutics Division of Janssen Products

Partners

ASCP -Pharmacists

ProCE Banner

GAPNA

ProCE Banner

Target Audience

This program is intended for physicians, pharmacists, advanced practice nurses, and other healthcare providers caring for older adults at risk of severe RSV disease.

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Assess risk for severe RSV development in adults according to age and comorbid conditions
  • Outline vaccine strategies under evaluation for RSV in older adults
  • Apply guideline and data-based RSV prevention strategies in older adults as they become available

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Faculty Disclosure

Primary Author

Spencer H. Durham, PharmD, BCPS, BCIDP

Assistant Clinical Professor
Pharmacy Practice
Auburn University Harrison School of Pharmacy
Auburn, Alabama
Clinical Pharmacist Specialist, Infectious Diseases
Department of Pharmacy
Central Alabama Veterans Health Care System
Montgomery, Alabama

Spencer H. Durham, PharmD, BCPS, BCIDP, has disclosed that he has received consulting fees from Shionogi and Thera Technologies.

Stefan Gravenstein, MD, MPH

Greer Professor of Geriatrics
Alpert Medical School of Brown University
Providence, Rhode Island

Stefan Gravenstein, MD, MPH, has disclosed that he has received funds for research support from the Genentech, Pfizer, Sanofi, and Seqirus; has received consulting fees from Pfizer and Sanofi; and serves on the data and safety monitoring board for Longeveron.

Barbara Resnick, PhD, CRNP

Professor
School of Nursing
University of Maryland
Nurse Practitioner
Roland Park Pace
Baltimore, Maryland

Barbara Resnick, PhD, CRNP, has no relevant conflicts of interest to report.

Staff Disclosure

Staff

Kiran Mir-Hudgeons, PhD

Clinical Editor

Kiran Mir-Hudgeons, PhD, has no relevant conflicts of interest to report.

Zachary Schwartz, MSc, ELS

Scientific Director

Zachary Schwartz, MSc, ELS, has no relevant conflicts of interest to report.

Instructions for Credit

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit Designation

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 contact hours.

Credit Designation

CCO designates this continuing education activity for 0.75 contact hours (0.075 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-21-134-H01-P.

Type of Activity: Knowledge

Upon successfully completing the post-test with a score of 50% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Additional Information

Participation in this self-study activity should be completed in approximately 0.75 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from July 21, 2021, through July 20, 2022:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 50% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.


Goal


The goal of this activity is to improve learners’ competence in identifying respiratory syncytial virus in older adults and understanding the ongoing prevention clinical research.